Customers buying home testing kits for COVID were often misled by third-party websites, new study finds
Home-testing kits sold online in the UK and US in the midst of the Coronavirus pandemic were provided with incomplete and in some cases, misleading information on how accurate they were, a new UK study by experts the Universities of Birmingham and Warwick has found.
Testing has been regarded as critical to managing the pandemic, the two main tests being molecular virus tests to detect current infection and antibody tests to detect previous infection. Outside of national testing programmes, multiple websites were found to selling both types of test in kit form for personal home use. These tests have subsequently been banned in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA).
The study, which is the first research into the accuracy of the information provided by websites selling tests for the virus, analysed 27 websites in the U and US which were selling tests in May 2020. The online information provided with each of the 41 tests (39 in the UK and 2 in the US) were analysed for completeness, accuracy and how informative the information was.
Of the 41 tests, only nine provided the name of the manufacturer of the test while only ten provided information on when to use the test. Information on accuracy was provided with 12 of the tests and just under half failed to provide information on how to interpret the results. Sensitivity and specificity information ranging from 97.5% to 100% for molecular tests and 100% for antibodies was provided for 27 of the 41 tests. However, researchers were only able to link these figures to manufacturer’s documents or publications for four of the tests.
while only 12 out of the 18 antibodies tests being sold explained that a positive result does not necessarily infer immunity from future infection. Researchers also found misleading information about regulatory approval with websites claiming endorsements from Public Health England, the NHS or the UK or other European governments. This is despite the fact that currently, no COVID-19 antibody tests have regulatory approval for home sampling or home testing.
The full paper ‘Information given by websites selling home self-sampling COVID-19 tests: An analysis of accuracy and completeness’ is available on medRxiv.
Professor Jon Deeks, co-author from the University of Birmingham’s Institute of Applied Health Research said: “Our analysis has found that many of these third party websites omitted trustworthy guidance on the timing of tests, the interpretation of results and the implications of results. It is crucial that all test users are given adequate and appropriate information to help them make safe and informed choices and best practice guidance should be developed to ensure the safety of these users. The role of the regulator in enforcing complete and accurate information should also be reviewed.”
Dr Sian Taylor-Phillips, lead author from the Warwick Medical School at the University of Warwick said: ““It is essential that people buying tests for COVID-19 are given complete and correct information. Our study shows this simply isn't happening at the moment. This could put people at risk of becoming infected or infecting others."
Notes to editors:
For more information please contact Sophie Belcher, Communications Manager, University of Birmingham, on +44 7815607157. Alternatively, contact the Press Office out of hours on +44 (0)7789 921165.
Full paper: ‘Information given by websites selling home self-sampling COVID-19 tests: An analysis of accuracy and completeness’ - https://medrxiv.org/cgi/content/short/2020.08.18.20177360v1